At a glance
- Originator Howard University
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 14 Mar 2001 Discontinued-Preclinical for Epilepsy in USA (PO)
- 23 Jan 1997 No-Development-Reported for Epilepsy in USA (PO)